TXNDC9 anticorps (AA 182-226) (Cy7)
Aperçu rapide pour TXNDC9 anticorps (AA 182-226) (Cy7) (ABIN1420532)
Antigène
Voir toutes TXNDC9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 182-226
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human TXNDC9
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IF(IHC-P) 1:50-200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- TXNDC9 (Thioredoxin Domain Containing 9 (TXNDC9))
-
Autre désignation
- TXNDC9
-
Sujet
-
Synonyms: APACD, PHLP3, Thioredoxin domain-containing protein 9, ATP-binding protein associated with cell differentiation, Protein 1-4, TXNDC9
Background: Significantly diminishes the chaperonin TCP1 complex ATPase activity, thus negatively impacts protein folding, including that of actin or tubulin.
-
ID gène
- 10190
-
UniProt
- O14530
-
Pathways
- Cell RedoxHomeostasis
Antigène
-